Donanemab – what we know about the latest Alzheimer’s drug - The drug is one of the new ‘disease modifying’ treatments for ...

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending watchdog said it “does not currently demonstrate value for the NHS”. The news ...

The retrospective study points to fewer suicidal thoughts or attempts among adolescents taking semaglutide or liraglutide.

The Medical and Social Assessment Boards (MSABs) will be replaced with a new European model of medical evaluation of citizens ...

At the 2024 GRx+Biosims conference, industry leaders and regulatory experts underscored the urgency of unifying global ...

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

The opinion rejects granting conditional marketing authorization to AB Science’s masitinib as an oral add-on treatment for ...